Sharecare (Nasdaq: SHCR), the digital health company that helps
people manage all their health in one place, today announced
financial results for the quarter ended June 30, 2023.
"Our integrated approach to delivering
comprehensive care solutions has proven successful in enhancing
user experiences, reducing costs, and measurably improving clinical
outcomes across populations, whether people are managing high-risk
and chronic conditions or simply require routine preventive care,"
said Jeff Arnold, chairman and CEO of Sharecare. "With our
continued investments in generative AI, advocacy, and home care, we
have the ability not only to generate personalized health insights
derived from individual and aggregated data and deliver more
tailored and engaging care solutions to people, but also to quickly
identify health risks within diverse customer populations and close
care gaps at scale, which is a win-win for our customers and their
members."
Second Quarter
2023 Financial Results All
comparisons, unless otherwise noted, are to the three months ended
June 30, 2022.
- Revenue of $110.4 million compared
to $103.8 million, an increase of $6.6 million, or 6.3%.
- Net loss attributable to Sharecare
of $35.1 million compared to $29.0 million, an increase to net loss
attributable to Sharecare of $6.1 million. Net loss attributable to
Sharecare in the second quarter of 2023 included $12.1 million in
non-cash stock compensation; $1.4 million in non-operating,
non-recurring costs; $8.2 million of reorganizational and severance
costs; and $3.8 million of other non-cash or non-operational
expense. Excluding these amounts, the adjusted net loss was $9.6
million in the current quarter.
- Adjusted EBITDA of $3.8 million
compared to $2.1 million, an increase to adjusted EBITDA of $1.7
million.
- Net loss per share of $0.10
compared to $0.08, an increase to net loss per share of $0.02.
- Adjusted net loss per share, which
excludes the impact of non-cash and non-operational amounts, was
$0.03 compared to $0.02, an increase to adjusted net loss per share
of $0.01.
Arnold added, “With the conclusion of our
strategic review, which we announced in the quarter, the Board came
to the unanimous decision that our three business channels –
Enterprise, Provider, and Life Sciences – complement one another
with a depth and breadth of capabilities that, together, create a
unique platform-driven ecosystem built for scale. We are confident
that the strategic alignment of these businesses allows us to seize
new growth opportunities and serve our expanding customer base and
their needs more effectively today and into the future, and we
remain committed to maximizing shareholder value.”
“Sharecare’s financial health remains strong,
and we are pleased with our performance in the second quarter,
expanding adjusted EBITDA margins, substantially improved cash
burn, and the robustness of our balance sheet – all of which will
help us reach our goal of cash flow breakeven by year's end," said
Justin Ferrero, president and chief financial officer of
Sharecare.
Financial Outlook
Third Quarter
2023 Financial GuidanceFor the
three months ending September 30, 2023, the Company expects:
- Revenue in the range of $111
million to $113 million
- Adjusted EBITDA in the range of $8
million to $10 million
Fiscal 2023
Financial GuidanceFor the twelve months ending
December 31, 2023, the Company continues to expect:
- Revenue in the range of $452.5
million to $460 million
- Adjusted EBITDA in the range of $25
million to $30 million
Ferrero added, "While our business will continue
to have some channel-level seasonality going forward, our expected
adjusted EBITDA in the third quarter is indicative of the emerging
underlying earnings power of Sharecare, driven in part by our $30
million annualized cost-savings initiative, which we also are on
track to achieve by the end of 2023.”
Conference CallThe Company will
host a conference call to review the second quarter results today,
Wednesday, August 9, 2023, at 8:00 a.m. EDT. The call can be
accessed by dialing (833) 636-1352 for U.S. participants or (412)
902-4148 for international participants, and referencing the
Sharecare earnings call; or via live audio webcast, available
online at https://investors.sharecare.com/. A webcast replay of the
call will be available for on-demand listening at the same link and
will remain available for approximately 90 days.
Non-GAAP Financial MeasuresIn
addition to our financial results determined in accordance with
U.S. GAAP, we believe the non-GAAP measures adjusted EBITDA,
adjusted net loss, and adjusted loss per share are useful in
evaluating our operating performance. We use adjusted EBITDA,
adjusted net loss, and adjusted loss per share to evaluate our
ongoing operations and for internal planning and forecasting
purposes. We believe that these non-GAAP financial measures, when
taken together with the corresponding GAAP financial measures,
provide meaningful supplemental information regarding our
performance by excluding certain items that may not be indicative
of our business, results of operations, or outlook. In particular,
we believe that the use of these non-GAAP measures is helpful to
our investors as these metrics are used by management in assessing
the health of our business and our operating performance. However,
non-GAAP financial information is presented for supplemental
informational purposes only, has limitations as an analytical tool,
and should not be considered in isolation or as a substitute for
financial information presented in accordance with GAAP. In
addition, other companies, including companies in our industry, may
calculate similarly-titled non-GAAP measures differently or may use
other measures to evaluate their performance, all of which could
reduce the usefulness of our non-GAAP financial measures.
The calculations and reconciliations of historic
adjusted EBITDA, adjusted net loss, and adjusted loss per share to
net loss, the most directly comparable financial measure stated in
accordance with GAAP, are provided below and in the accompanying
financial tables. Investors are encouraged to review the
reconciliations and not to rely on any single financial measure to
evaluate our business.
We have not reconciled adjusted EBITDA guidance
to net loss because we do not provide guidance for net loss or for
items that we do not consider indicative of our ongoing
performance, including, but not limited to, the impact of
significant non-recurring items, as certain of these items are out
of our control and/or cannot be reasonably predicted. Accordingly,
reconciliations of adjusted EBITDA guidance to the corresponding
U.S. GAAP measures are not available without unreasonable
effort.
Adjusted EBITDAWe calculate
adjusted EBITDA as net loss adjusted to exclude
(i) depreciation and amortization, (ii) interest income,
(iii) interest expense, (iv) income tax expense, (v) other
income (expense) (non-operating), (vi)
share-based compensation, (vii) warrants issued with revenue
contracts, (viii) amortization of non-cash payment for research and
development, (ix) net costs associated with exiting a contract, (x)
non-operating, non-recurring costs, (xi) reorganizational and
severance costs, and (xii) acquisition-related costs. We do not
view the items excluded as representative of normal, recurring,
cash operating expenses necessary to operate the Company’s lines of
business and services.
Adjusted Net LossWe calculate
adjusted net loss as net loss attributable to Sharecare, Inc.
adjusted to exclude (i) amortization of acquired intangibles, (ii)
amortization of deferred financing fees, (iii) change in fair value
of warrant liability and contingent consideration, (iv) share-based
compensation, (v) warrants issued with revenue contracts, (vi)
amortization of non-cash payment for research and development,
(vii) net costs associated with exiting a contract, (viii)
non-operating, non-recurring costs, (ix) reorganizational and
severance costs, and (x) acquisition related costs. We do not view
the items excluded as representative of normal, recurring, cash
operating expenses necessary to operate the Company’s lines of
business and services.
Adjusted Loss Per ShareWe
calculate adjusted lost per share as adjusted net loss, as defined
above, divided by the number of weighted average common shares
outstanding - basic and diluted.
About SharecareSharecare is the
leading digital health company that helps people – no matter where
they are in their health journey – unify and manage all their
health in one place. Our comprehensive and data-driven virtual
health platform is designed to help people, providers, employers,
health plans, government organizations, and communities optimize
individual and population-wide well-being by driving positive
behavior change. Driven by our philosophy that we are all together
better, at Sharecare, we are committed to supporting each
individual through the lens of their personal health and making
high-quality care more accessible and affordable for everyone. To
learn more, visit www.sharecare.com.
Important Notice Regarding
Forward-Looking StatementsThis press release contains
forward-looking statements within the meaning of the U.S. Private
Securities Litigation Reform Act of 1995 that are based on beliefs
and assumptions and on information currently available. In some
cases, you can identify forward-looking statements by the following
words: “outlook,” “target,” “reflect,” “on track,” “foresees,”
“future,” “may,” “deliver,” “will,” “shall,” “could,” “would,”
“should,” “expect,” “intend,” “plan,” “anticipate,” “believe,”
“estimate,” “predict,” “project,” “potential,” “continue,”
“ongoing” or the negative of these terms, other comparable
terminology (although not all forward-looking statements contain
these words), or by discussions of strategy, plans, or intentions.
These statements involve risks, uncertainties and other factors
that may cause actual results, levels of activity, performance or
achievements to be materially different from the information
expressed or implied by these forward-looking statements. Although
we believe that we have a reasonable basis for each forward-looking
statement contained in this press release, we caution you that
these statements are based on a combination of facts and factors
currently known by us and our projections of the future, about
which we cannot be certain.
Forward-looking statements in this press release
include, but are not limited to, statements regarding our long-term
strategy and positioning, growth, globalization and other strategic
cost optimization initiatives and the corresponding benefits,
including long-term growth, margin improvement and cash flow
improvements, and partnerships or other relationships with third
parties or customers, in each case on our future growth objectives
and statements regarding our future results and outlook, including
those under the caption “Financial Outlook.”
We cannot assure you that the forward-looking
statements in this press release will prove to be accurate. These
forward-looking statements are subject to a number of significant
risks and uncertainties that could cause actual results to differ
materially from expected results. For example, the Company’s
Financial Outlook assumes business currently under contract and
satisfaction by our customers of their contractual obligations
under those agreements, which is not within the Company’s control.
If a customer fails to satisfy its contractual obligations, actual
revenue and Adjusted EBITDA could be negatively impacted.
Descriptions of some of the other factors that could cause actual
results to differ materially from these forward-looking statements
are discussed in more detail in our filings with the U.S.
Securities and Exchange Commission (the "SEC"), including the Risk
Factors section of the Company's Annual Report on Form 10-K filed
with the SEC on March 30, 2023. Furthermore, if the forward-looking
statements prove to be inaccurate, the inaccuracy may be material.
In light of the significant uncertainties in these forward-looking
statements, you should not regard these statements as a
representation or warranty by us or any other person that we will
achieve our objectives and plans in any specified time frame, or at
all. The forward-looking statements in this press release represent
our views as of the date of this press release. We anticipate that
subsequent events and developments will cause our views to change.
However, while we may elect to update these forward-looking
statements at some point in the future, we have no current
intention of doing so except to the extent required by applicable
law. You should, therefore, not rely on these forward-looking
statements as representing our views as of any date subsequent to
the date of this press release.
Media Relations:Jen Martin
Halljen@sharecare.com
Investor Relations:Bob
EastSharecareIR@westwicke.com
SHARECARE,
INC.CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)(In thousands, except share and
per share amounts)
|
Three Months EndedJune 30, |
|
Six Months EndedJune 30, |
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
Revenue (inclusive of $18,045
and $8,051 of related party revenue for the three months ended June
30, 2023 and 2022, respectively, and $36,793 and $15,619 of related
party revenue for the six months ended June 30, 2023 and 2022,
respectively) |
$ |
110,353 |
|
|
$ |
103,823 |
|
|
$ |
226,648 |
|
|
$ |
204,533 |
|
Costs and operating
expenses: |
|
|
|
|
|
|
|
Costs of revenue (exclusive of
depreciation and amortization; inclusive of $9,534 and $0 of
related party costs for three months ended June 30, 2023 and 2022,
respectively, and $20,396 and $0 of related party costs for the six
months ended June 30, 2023 and 2022, respectively) |
|
62,948 |
|
|
|
53,238 |
|
|
|
130,840 |
|
|
|
104,730 |
|
Sales and marketing |
|
14,959 |
|
|
|
14,155 |
|
|
|
30,309 |
|
|
|
28,666 |
|
Product and technology |
|
17,035 |
|
|
|
17,680 |
|
|
|
37,843 |
|
|
|
37,101 |
|
General and
administrative |
|
35,371 |
|
|
|
43,491 |
|
|
|
69,490 |
|
|
|
99,489 |
|
Depreciation and
amortization |
|
14,184 |
|
|
|
10,901 |
|
|
|
28,965 |
|
|
|
20,778 |
|
Total costs and operating expenses |
|
144,497 |
|
|
|
139,465 |
|
|
|
297,447 |
|
|
|
290,764 |
|
Loss from operations |
|
(34,144 |
) |
|
|
(35,642 |
) |
|
|
(70,799 |
) |
|
|
(86,231 |
) |
Other income (expense): |
|
|
|
|
|
|
|
Interest income |
|
1,646 |
|
|
|
102 |
|
|
|
3,326 |
|
|
|
131 |
|
Interest expense |
|
(453 |
) |
|
|
(539 |
) |
|
|
(882 |
) |
|
|
(1,031 |
) |
Other (expense) income |
|
(2,631 |
) |
|
|
6,827 |
|
|
|
(2,201 |
) |
|
|
19,672 |
|
Total other (expense) income |
|
(1,438 |
) |
|
|
6,390 |
|
|
|
243 |
|
|
|
18,772 |
|
Loss before income tax expense |
|
(35,582 |
) |
|
|
(29,252 |
) |
|
|
(70,556 |
) |
|
|
(67,459 |
) |
Income tax expense |
|
(65 |
) |
|
|
(269 |
) |
|
|
(96 |
) |
|
|
(361 |
) |
Net loss |
|
(35,647 |
) |
|
|
(29,521 |
) |
|
|
(70,652 |
) |
|
|
(67,820 |
) |
Net loss attributable to
noncontrolling interest in subsidiaries |
|
(504 |
) |
|
|
(496 |
) |
|
|
(850 |
) |
|
|
(594 |
) |
Net loss attributable to Sharecare, Inc. |
$ |
(35,143 |
) |
|
$ |
(29,025 |
) |
|
$ |
(69,802 |
) |
|
$ |
(67,226 |
) |
|
|
|
|
|
|
|
|
Net loss per share
attributable to common stockholders, basic and diluted |
$ |
(0.10 |
) |
|
$ |
(0.08 |
) |
|
$ |
(0.20 |
) |
|
$ |
(0.19 |
) |
Weighted-average common shares
outstanding, basic and diluted |
|
354,049,808 |
|
|
|
347,334,401 |
|
|
|
353,490,234 |
|
|
|
346,122,333 |
|
SHARECARE,
INC.CONSOLIDATED BALANCE
SHEETS(Unaudited)(In thousands,
except share and per share amounts)
|
As of June 30,2023 |
|
As of December 31,2022 |
Assets |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents |
$ |
144,162 |
|
|
$ |
182,508 |
|
Accounts receivable, net (net of allowance for doubtful accounts of
$8,145 and $7,197, respectively) |
|
123,856 |
|
|
|
116,877 |
|
Other receivables |
|
2,329 |
|
|
|
4,114 |
|
Prepaid expenses |
|
10,420 |
|
|
|
12,612 |
|
Other current assets |
|
4,890 |
|
|
|
4,515 |
|
Total current assets |
|
285,657 |
|
|
|
320,626 |
|
Property and equipment, net |
|
4,595 |
|
|
|
5,082 |
|
Other long-term assets |
|
20,426 |
|
|
|
20,362 |
|
Intangible assets, net |
|
152,763 |
|
|
|
163,114 |
|
Goodwill |
|
191,946 |
|
|
|
191,817 |
|
Total assets |
$ |
655,387 |
|
|
$ |
701,001 |
|
Liabilities,
Redeemable Convertible Preferred Stock and Stockholders’
Equity |
|
|
|
Current liabilities: |
|
|
|
Accounts payable |
$ |
25,719 |
|
|
$ |
8,838 |
|
Accrued expenses and other current liabilities |
|
79,569 |
|
|
|
81,627 |
|
Deferred revenue |
|
6,931 |
|
|
|
9,032 |
|
Contract liabilities, current |
|
768 |
|
|
|
1,535 |
|
Total current liabilities |
|
112,987 |
|
|
|
101,032 |
|
Warrant liabilities |
|
3,307 |
|
|
|
2,441 |
|
Long-term debt |
|
364 |
|
|
|
— |
|
Other long-term liabilities |
|
9,565 |
|
|
|
16,723 |
|
Total liabilities |
|
126,223 |
|
|
|
120,196 |
|
Commitments and contingencies |
|
|
|
Series A convertible redeemable preferred shares, $0.0001 par
value; 5,000,000 shares authorized; 5,000,000 shares
issued and outstanding, aggregate liquidation
preference of $50,000 as of June 30, 2023 and December 31,
2022 |
|
58,205 |
|
|
|
58,205 |
|
Stockholders’ equity: |
|
|
|
Common stock, $0.0001 par value; 600,000,000 and 600,000,000 shares
authorized; 356,593,964 and 354,463,620 shares issued
and outstanding as of June 30, 2023 and December 31,
2022, respectively |
|
35 |
|
|
|
35 |
|
Additional paid-in capital |
|
1,139,594 |
|
|
|
1,120,024 |
|
Accumulated other comprehensive loss |
|
(2,370 |
) |
|
|
(2,794 |
) |
Accumulated deficit |
|
(666,677 |
) |
|
|
(595,820 |
) |
Total Sharecare stockholders’ equity |
|
470,582 |
|
|
|
521,445 |
|
Noncontrolling interest in subsidiaries |
|
377 |
|
|
|
1,155 |
|
Total stockholders’ equity |
|
470,959 |
|
|
|
522,600 |
|
Total liabilities, redeemable convertible preferred stock and
stockholders’ equity |
$ |
655,387 |
|
|
$ |
701,001 |
|
SHARECARE,
INC.RECONCILIATION OF GAAP NET LOSS TO ADJUSTED
EBITDA(Unaudited)(In
thousands)
|
Three Months EndedJune 30, |
|
Six Months EndedJune 30, |
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
Net loss |
$ |
(35,647 |
) |
|
$ |
(29,521 |
) |
|
$ |
(70,652 |
) |
|
$ |
(67,820 |
) |
Add: |
|
|
|
|
|
|
|
Depreciation and
amortization |
|
14,184 |
|
|
|
10,901 |
|
|
|
28,965 |
|
|
|
20,778 |
|
Interest income |
|
(1,646 |
) |
|
|
(102 |
) |
|
|
(3,326 |
) |
|
|
(131 |
) |
Interest expense |
|
453 |
|
|
|
539 |
|
|
|
882 |
|
|
|
1,031 |
|
Income tax expense |
|
65 |
|
|
|
269 |
|
|
|
96 |
|
|
|
361 |
|
Other expense (income) |
|
2,631 |
|
|
|
(6,827 |
) |
|
|
2,201 |
|
|
|
(19,672 |
) |
Share-based compensation |
|
12,149 |
|
|
|
18,177 |
|
|
|
22,116 |
|
|
|
51,287 |
|
Warrants issued with revenue
contracts |
|
14 |
|
|
|
14 |
|
|
|
28 |
|
|
|
34 |
|
Amortization of non-cash
payment for research and development |
|
1,190 |
|
|
|
424 |
|
|
|
2,380 |
|
|
|
847 |
|
Net costs associated with
exiting a contract(a) |
|
505 |
|
|
|
1,249 |
|
|
|
1,222 |
|
|
|
2,923 |
|
Non-operating, non-recurring
costs(b) |
|
1,427 |
|
|
|
2,281 |
|
|
|
3,142 |
|
|
|
5,037 |
|
Reorganizational and severance
costs(c) |
|
8,224 |
|
|
|
3,482 |
|
|
|
18,036 |
|
|
|
6,059 |
|
Acquisition-related costs |
|
267 |
|
|
|
1,249 |
|
|
|
825 |
|
|
|
3,224 |
|
Adjusted EBITDA(d) |
$ |
3,816 |
|
|
$ |
2,135 |
|
|
$ |
5,915 |
|
|
$ |
3,958 |
|
(a) |
For the three months ended June 30, 2023, represents revenue of
$1.8 million and costs of revenue of $2.3 million. For the six
months ended June 30, 2023, represents revenue of $3.8 million and
costs of revenue of $5.0 million. |
(b) |
For the three months ended June 30, 2023, primarily represents
costs related to the Company's transformational enterprise resource
planning system (ERP) implementation of $0.5 million and
contractual obligations of $0.3 million. For the six months ended
June 30, 2023, primarily represents costs related to the ERP
implementation of $0.9 million and contractual obligations of $0.7
million. |
(c) |
For the three months ended June 30, 2023, represents costs related
to globalizing the Company's workforce of $7.3 million and
severance of $0.9 million. For the six months ended June 30, 2023,
represents costs related to globalizing the Company's workforce of
$16.3 million and severance of $1.7 million. |
(d) |
Includes non-cash amortization associated with contract liabilities
recorded in connection with acquired businesses. |
SHARECARE,
INC.RECONCILIATION OF GAAP NET LOSS ATTRIBUTABLE
TO SHARECARE TO ADJUSTED NET LOSS AND ADJUSTED
LOSS PER
SHARE(Unaudited)(In thousands,
except share and per share data)
|
Three Months EndedJune 30, |
|
Six Months EndedJune 30, |
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
Net loss attributable to
Sharecare, Inc. |
$ |
(35,143 |
) |
|
$ |
(29,025 |
) |
|
$ |
(69,802 |
) |
|
$ |
(67,226 |
) |
Add: |
|
|
|
|
|
|
|
Amortization of acquired
intangibles(a) |
|
1,633 |
|
|
|
1,631 |
|
|
|
3,265 |
|
|
|
3,263 |
|
Amortization of deferred
financing fees |
|
— |
|
|
|
70 |
|
|
|
31 |
|
|
|
138 |
|
Change in fair value of
warrant liability and contingent consideration |
|
96 |
|
|
|
(6,374 |
) |
|
|
(42 |
) |
|
|
(18,742 |
) |
Share-based compensation |
|
12,149 |
|
|
|
18,177 |
|
|
|
22,116 |
|
|
|
51,287 |
|
Warrants issued with revenue
contracts |
|
14 |
|
|
|
14 |
|
|
|
28 |
|
|
|
34 |
|
Amortization of non-cash
payment for research and development |
|
1,190 |
|
|
|
424 |
|
|
|
2,380 |
|
|
|
847 |
|
Net costs associated with
exiting a contract(b) |
|
505 |
|
|
|
1,249 |
|
|
|
1,222 |
|
|
|
2,923 |
|
Non-operating, non-recurring
costs(c) |
|
1,427 |
|
|
|
2,281 |
|
|
|
3,142 |
|
|
|
5,037 |
|
Reorganizational and severance
costs(d) |
|
8,224 |
|
|
|
3,482 |
|
|
|
18,036 |
|
|
|
6,059 |
|
Acquisition-related costs |
|
267 |
|
|
|
1,249 |
|
|
|
825 |
|
|
|
3,224 |
|
Adjusted net loss(e) |
$ |
(9,638 |
) |
|
$ |
(6,822 |
) |
|
$ |
(18,799 |
) |
|
$ |
(13,156 |
) |
|
|
|
|
|
|
|
|
Weighted-average common shares
outstanding, basic and diluted |
|
354,049,808 |
|
|
|
347,334,401 |
|
|
|
353,490,234 |
|
|
|
346,122,333 |
|
|
|
|
|
|
|
|
|
Loss per share |
$ |
(0.10 |
) |
|
$ |
(0.08 |
) |
|
$ |
(0.20 |
) |
|
$ |
(0.19 |
) |
Adjusted loss per share |
$ |
(0.03 |
) |
|
$ |
(0.02 |
) |
|
$ |
(0.05 |
) |
|
$ |
(0.04 |
) |
(a) |
Represents non-cash expenses related to the amortization of
intangibles in connection with acquired businesses. |
(b) |
For the three months ended June
30, 2023, represents revenue of $1.8 million and costs of revenue
of $2.3 million. For the six months ended June 30, 2023, represents
revenue of $3.8 million and costs of revenue of $5.0 million. |
(c) |
For the three months ended June
30, 2023, primarily represents costs related to the Company's
transformational enterprise resource planning system (ERP)
implementation of $0.5 million and contractual obligations of $0.3
million. For the six months ended June 30, 2023, primarily
represents costs related to the ERP implementation of $0.9 million
and contractual obligations of $0.7 million. |
(d) |
For the three months ended June
30, 2023, represents costs related to globalizing the Company's
workforce of $7.3 million and severance of $0.9 million. For the
six months ended June 30, 2023, represents costs related to
globalizing the Company's workforce of $16.3 million and severance
of $1.7 million. |
(e) |
The income tax effect of the
Company’s non-GAAP reconciling items are offset by valuation
allowance adjustments of the same amount given the Company is in a
full valuation allowance position. |
Sharecare (NASDAQ:SHCR)
Historical Stock Chart
From Apr 2024 to May 2024
Sharecare (NASDAQ:SHCR)
Historical Stock Chart
From May 2023 to May 2024